- Home
- VVX vs SLNO Comparison
VVX vs SLNO Comparison
Compare VVX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVX
- SLNO
- Stock Information
- Founded
- VVX 2014
- SLNO 1999
- Country
- VVX United States
- SLNO United States
- Employees
- VVX N/A
- SLNO N/A
- Industry
- VVX Diversified Commercial Services
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VVX Consumer Discretionary
- SLNO Health Care
- Exchange
- VVX Nasdaq
- SLNO Nasdaq
- Market Cap
- VVX 1.4B
- SLNO 3.8B
- IPO Year
- VVX 2014
- SLNO 2014
- Fundamental
- Price
- VVX $48.56
- SLNO $86.14
- Analyst Decision
- VVX Buy
- SLNO Strong Buy
- Analyst Count
- VVX 9
- SLNO 9
- Target Price
- VVX $64.11
- SLNO $103.33
- AVG Volume (30 Days)
- VVX 245.3K
- SLNO 1.0M
- Earning Date
- VVX 08-05-2025
- SLNO 08-06-2025
- Dividend Yield
- VVX N/A
- SLNO N/A
- EPS Growth
- VVX N/A
- SLNO N/A
- EPS
- VVX 1.29
- SLNO N/A
- Revenue
- VVX $4,327,514,000.00
- SLNO N/A
- Revenue This Year
- VVX $4.02
- SLNO N/A
- Revenue Next Year
- VVX $4.80
- SLNO N/A
- P/E Ratio
- VVX $37.54
- SLNO N/A
- Revenue Growth
- VVX 7.38
- SLNO N/A
- 52 Week Low
- VVX $41.08
- SLNO $39.41
- 52 Week High
- VVX $69.75
- SLNO $86.79
- Technical
- Relative Strength Index (RSI)
- VVX 62.52
- SLNO 62.72
- Support Level
- VVX $44.51
- SLNO $78.48
- Resistance Level
- VVX $49.35
- SLNO $86.67
- Average True Range (ATR)
- VVX 1.25
- SLNO 2.78
- MACD
- VVX 0.59
- SLNO 0.40
- Stochastic Oscillator
- VVX 85.93
- SLNO 67.95
About VVX V2X Inc.
V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.